Target Identification and Validation Archives - Page 3 of 8

How Does It Work? | Adenovirus Vaccines

This week, we delve into Adenovirus Vaccines as part of our “How Does It Work?” 3D MoA animation series examining...

How Does It Work? | mRNA Vaccines

If you’ve ever read about mRNA vaccines and wondered, “How Does It Work?” This week’s installment of our video series...

How Does It Work? | Peptide-Oligonucleotide Conjugates

This week’s episode of our “How Does It Work?” series features Peptide-Oligonucleotide Conjugates. Peptide-oligonucleotide conjugates are made up of peptide...

How Does It Work? | Aptamers

Nucleic acids have long been regarded as biological compounds for storing and transferring information. However, their functionalities are far more...

How Does It Work? | Individualized Oligonucleotide Therapies

In this week’s episode of our “How Does It Work?” video series, we explore Individualized Oligonucleotide Therapies. Around 6 billion...

How Does It Work? | Antibody Drug Conjugates

In this week’s installment of our “How Does It Work?” video series, we explore Antibody Drug Conjugates. Monoclonal antibodies are...

How Does It Work? | Antisense Oligonucleotide Therapy

In this week’s installment of our “How Does It Work?” video series, we’ll explore Antisense Oligonucleotide Therapy. Errors in DNA,...

PD-1 Blockade Protein in 4th Generation Armored CAR-T Cells Enhances Cytotoxicity Effect with in vitro...

Chimeric antigen receptor (CAR)-T cells are genetically engineered T cells that express a surface receptor to recognize tumor-associated antigens (TAA)....